
STARRY SEA ACQUISITION CORP
74
Recent developments include the announcement of a merger agreement with SuperiorMed Holdings Limited and the postponement of the shareholder meeting to October 19, 2026, with an extension of the redemption request deadline.
- On August 22, 2026, STARRY SEA ACQUISITION CORP announced entering into an agreement and plan of merger with SuperiorMed Holdings Limited [N2].
- On October 9, 2026, the company announced postponement of the Extraordinary General Meeting in lieu of an Annual General Meeting to October 19, 2026, and extension of the redemption request deadline [N1].
STARRY SEA ACQUISITION CORP is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a target company. It has not commenced operations or generated revenues. The company raised proceeds through an IPO and private placement, which are held in a trust account until a business combination is consummated or shares are redeemed. The management team focuses on leveraging their operational and capital markets expertise to identify targets with strong recurring revenue, defensible market positions, and growth potential. The company announced a merger agreement with SuperiorMed Holdings Limited and has postponed its shareholder meeting to facilitate this process.
STARRY SEA ACQUISITION CORP is a blank check company formed in late 2024 to pursue a business combination. It completed an IPO in August 2025, raising $57.5 million placed in a trust account. The company has no operating revenues and limited liquidity outside the trust. It announced a merger agreement with SuperiorMed Holdings Limited in August 2026 and postponed its shareholder meeting to October 19, 2026. Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
The company’s management team has extensive experience and networks to source and execute attractive business combinations. The announced merger agreement with SuperiorMed Holdings Limited represents progress toward completing an initial business combination. The SPAC structure offers target companies a streamlined path to public markets, which may attract quality candidates. The trust account funds provide capital security for shareholders until a combination is consummated or shares redeemed.
The company currently has no operating revenues and limited liquidity outside the trust account, with a very low current ratio indicating potential liquidity constraints. The postponement of the shareholder meeting and extension of redemption deadlines may indicate delays or challenges in completing the business combination. As a blank check company, there is inherent uncertainty and risk related to identifying and consummating a suitable business combination within the prescribed timeframe.
As a blank check company, STARRY SEA ACQUISITION CORP's moat derives from its management team's deal execution capabilities, extensive networks, and access to public capital markets. The company offers an alternative to traditional IPOs for target businesses, potentially providing faster and less costly access to public equity. However, as a SPAC without operating history or revenues, its competitive advantage depends heavily on successful identification and execution of a business combination.
• Liquidity Risk: The company has minimal cash and equivalents outside the trust account and a current ratio of 0.04 as of September 30, 2026, indicating limited ability to cover short-term liabilities without the trust funds.
• Business Combination Execution Risk: Delays such as the postponement of the shareholder meeting and extension of redemption deadlines may impact the timing and certainty of completing the initial business combination.
• Operational Risk: As a blank check company with no operating history or revenues, the company’s success depends entirely on identifying and consummating a suitable business combination.
Business trends: The company is actively pursuing a business combination, recently announcing a merger agreement and managing shareholder meeting scheduling.
Execution milestones: Completion of the initial business combination and shareholder approvals remain critical milestones.
Key risks: Execution delays, limited liquidity outside the trust account, and inherent uncertainties of blank check companies pose risks.
High visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- STARRY SEA ACQUISITION CORP is a blank check company formed on December 5, 2024, for the purpose of effecting a business combination such as a merger or acquisition [S1].
- The company has not commenced operations nor generated revenues to date; activities have been limited to formation, IPO, and search for initial business combination [S1].
- The IPO was completed on August 11, 2025, raising $57.5 million placed in a trust account for the benefit of public shareholders [S1].
- The trust account funds are invested in cash, U.S. government treasury bills, or money market funds and are restricted until completion of the initial business combination or redemption of shares [S1].
- The company’s sponsor is Starry Sea Investment Limited, a British Virgin Islands entity, which purchased founder shares and private placement units [S1].
- The company’s management team has extensive experience in deal execution, capital markets, and operational expertise, aiming to identify targets with strong recurring revenue, defensible market positions, and growth potential [S1].
- The company announced entering into an agreement and plan of merger with SuperiorMed Holdings Limited on August 22, 2026 [N2].
- The company announced postponement of its Extraordinary General Meeting to October 19, 2026, and extension of redemption request deadline [N1].
- As of September 30, 2026, the company had current assets of $23,768 and current liabilities of $548,344, resulting in a current ratio of 0.04 and cash ratio of 0, indicating very limited liquidity outside the trust account [S2].
- Net income reported for the period ending September 30, 2026, was $138,347 [S2].
- Basic and diluted EPS were -$0.02 as of March 31, 2026 [S2].
- The company’s funds outside the trust account are minimal, with no cash and equivalents reported as of September 30, 2025 [S2].
- The company’s business strategy includes leveraging management’s network and expertise to identify and execute a business combination with a target company that benefits from being public and has attractive risk-adjusted returns [S1].
Generated 2026-11-16
- S1 | 2026-04-02 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-10-09 | www.nasdaq.com | STARRY SEA ACQUISITION CORP Announces Postponement of the Extraordinary General Meeting in Lieu of an Annual General Meeting to October 19, 2026 and Extension of Redemption Request Deadline | https://www.nasdaq.com/press-release/starry-sea-acquisition-corp-announces-postponement-extraordinary-general-meeting-lieu
- N2 | 2026-08-22 | www.nasdaq.com | SuperiorMed Holdings Limited Announces Entering into an Agreement and Plan of Merger with Starry Sea Acquisition Corp | https://www.nasdaq.com/press-release/superiormed-holdings-limited-announces-entering-agreement-and-plan-merger-starry-sea
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


